VolitionRx Limited (VNRX) compared with its closest peers (QCLS, IMDX, BMRA, ISPC, AIDX). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Q/C Technologies, Insight Molecular Diagnostics, Biomerica, ImmuCell and Alpha Teknova share VolitionRx's sub-industry, diagnostics makers.
| Company | Market Cap | P/E |
|---|---|---|
| Q/C Technologies, Inc. (QCLS) | $15.68M | -0.5 |
| Insight Molecular Diagnostics Inc. (IMDX) | $131.55M | -4.5 |
| Biomerica, Inc. (BMRA) | $10.05M | -1.4 |
| iSpecimen Inc. (ISPC) | $3.78M | -0.1 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $8.05M | — |
| BNB Plus Corp. (BNBX) | $1.08M | — |
| OneMedNet Corporation (ONMD) | — | — |
| Absci Corporation (ABSI) | $1.37B | -4.1 |
| ImmuCell Corporation (ICCC) | $89.88M | 114.2 |
| Alpha Teknova, Inc. (TKNO) | $398.35M | -11.8 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
VNRX overview · VNRX earnings · VNRX financials · VNRX KPIs · VNRX documents · VNRX ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.